Nathan A. Brooks
Expertise in
4
conditions

Dr. Nathan A. Brooks

Oncology
UPMC Urology
100 Corporate Ctr Drive, Suite 100, 
Camp Hill, PA 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
4
conditions
UPMC Urology
100 Corporate Ctr Drive, Suite 100, 
Camp Hill, PA 

Overview

Nathan Brooks, MD, is a fellowship-trained urologic oncologist with UPMC Urology of Central PA. He received his medical degree from the University of Oklahoma Tulsa School of Community Medicine and completed his residency at the University of Iowa, followed by his fellowship in cancer care at MD Anderson Cancer Center. Dr. Brooks’ clinical interests include urologic oncology, including cancers of the prostate, kidney, penis, testicle, and adrenal gland, with specific expertise in the treatment of bladder cancer. His interests also include kidney stones, robotic and laparoscopic surgery, lower urinary tract symptoms, erectile dysfunction, and LGBTQ+ care, including gender affirming orchiectomy. He has authored more than 30 papers, book chapters, and online articles on urologic oncology topics and is a member of American Urological Association and the Society of Urologic Oncology.  Outside of medicine, Dr. Brooks enjoys spending time with family, biking, hiking, kayaking, reading, and cooking.   LGBTQIA+ Affirming: This provider has completed training on how to create a safe, comfortable, and welcoming environment for LGBTQIA+ patients. This provider may or may not offer LGBTQIA+ specific medical or surgical care. Please ask when scheduling.

Dr. Brooks is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Prostate Cancer, Ureteroscopy, and Lithotripsy.

He is actively involved in clinical research, co-authoring 31 peer reviewed articles. Dr. Brooks is currently accepting new patients.

Specialties

Oncology

Fellowships

Univ of Texas MD Anderson Cancer Center

Hospital Affiliations

Upmc Hanover
Upmc Lititz
Upmc Carlisle
Upmc Memorial
Upmc Pinnacle Hospitals

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Avalon Health Care
  • MEDICARE PDP
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

UPMC Urology
100 Corporate Ctr Drive, Suite 100, Camp Hill, PA 17011
Other Locations
UPMC Urology
815 Sir Thomas Court, Floor 2, Harrisburg, PA 17109

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

31 Total Publications

LY3410738, a Covalent Inhibitor of Mutant IDH1/2, is Effective in Acute Myeloid Leukemia Preclinical Models.
LY3410738, a Covalent Inhibitor of Mutant IDH1/2, is Effective in Acute Myeloid Leukemia Preclinical Models.
Journal: Blood cancer discovery
Published: November 18, 2025
Similar Doctors
Expertise in
20
conditions
Expertise in
20
conditions
Referral may be required

The Milton S. Hershey Medical Center

500 University Dr, 
Hershey, PA 
 (13.5 miles away)
800-243-1455
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Monika Joshi is an Oncologist practicing medicine in Hershey, Pennsylvania. Dr. Joshi is highly rated in 20 conditions, according to our data. Her clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Renal Cell Carcinoma (RCC), and Bone Marrow Aspiration.

Expertise in
27
conditions
Expertise in
27
conditions
Referral may be required
Before you request

Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville

10803 Falls Road, Pavilion III STE 1500, 
Lutherville, MD 
 (57.1 miles away)
410-583-2970
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dr. Daniel Laheru is a cancer specialist in Baltimore, caring for patients with pancreatic cancer, colorectal cancer and neuroendocrine cancers. Dr. Laheru serves as co-director of the Skip Viragh Center for Pancreas Cancer Clinical Research and Patient Care at Johns Hopkins Medicine. Dr. Laheru received his undergraduate degree in chemistry from The University of Utah. He earned his M.D. at Baylor College of Medicine. He completed his residency at The University of Utah Hospital and Clinics and performed a fellowship in medical oncology at The Johns Hopkins University School of Medicine and The Johns Hopkins Oncology Center. Dr. Laheru joined the Johns Hopkins faculty in 2001. Dr. Laheru's research interests include pancreatic cancer and chemotherapy resistance in pancreatic cancer. With Elizabeth Jaffee, M.D., he developed a vaccine that supercharges the immune system and causes immune cells, which tend to be tolerant of cancer, to seek out and kill pancreatic cancer cells throughout the body. He has given numerous invited talks on pancreatic cancer and other cancers both nationally and internationally. He has authored over 200 papers focused on pancreatic cancer. Dr. Laheru serves as associate editor of Annals of Pancreatic Cancer. He has been recognized by the American Society of Clinical Oncology with the Young Investigator Award, by the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as an Isaac and Catharine Hecht Scholar and has been elected to the Miller-Coulson Academy of Clinical Excellence. He is a member of the American College of Physicians, the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Laheru is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Laheru is board certified in American Board Of Internal Medicine. Dr. Laheru is currently accepting new patients.

Expertise in
7
conditions
Dr. Jonathan A. Bernstein
Hematology | Oncology
Expertise in
7
conditions
Dr. Jonathan A. Bernstein
Hematology | Oncology
Referral may be required

The Milton S. Hershey Medical Center

500 University Dr, 
Hershey, PA 
 (13.5 miles away)
800-243-1455
Languages Spoken:
English
See accepted insurances

Jonathan Bernstein is a Hematologist and an Oncologist practicing medicine in Hershey, Pennsylvania. Dr. Bernstein is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Chronic Spontaneous Urticaria (CSU), Hemophilia A, Mast Cell Activation Syndrome (MCAS), and Chronic Rhinosinusitis with Nasal Polyps (CRSwNP).

Frequently Asked Questions about Dr. Nathan A. Brooks

How do I make an appointment with Dr. Nathan A. Brooks?

You can book an appointment with Dr. Nathan A. Brooks by calling their office at 717-763-1174. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Nathan A. Brooks a top-rated expert for Bladder Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Nathan A. Brooks is classified as an Advanced expert for Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Nathan A. Brooks specialize in?

While Dr. Nathan A. Brooks is a Oncology, they have specific expertise in Bladder Cancer, Urothelial Cancer, and Prostate Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Nathan A. Brooks participate in research or clinical trials?

Yes. Dr. Nathan A. Brooks has published 31 articles and abstracts on conditions like Bladder Cancer. You can view a list of Dr. Nathan A. Brooks's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Nathan A. Brooks accept my insurance?

Dr. Nathan A. Brooks accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 717-763-1174 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Brooks's expertise for a condition
ConditionClose
      View All 23 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile